Inactive Instrument

Company Breathtec Biomedical Inc Deutsche Boerse AG

Equities

Biotechnology & Medical Research

Business Summary

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.

Managers

Managers TitleAgeSince
Chief Executive Officer 59 18-02-28
Director of Finance/CFO 46 21-11-30
Chief Operating Officer 41 21-02-28
Chief Tech/Sci/R&D Officer - 21-02-28

Members of the board

Members of the board TitleAgeSince
Chairman 79 21-09-07
Chief Executive Officer 59 18-02-28
Director/Board Member 52 21-09-21
Director of Finance/CFO 46 21-11-30
Director/Board Member 55 15-10-25
Director/Board Member - 22-02-27

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 21,940,779 17,393,981 ( 79.28 %) 0 79.28 %

Shareholders

NameEquities%Valuation
AlphaNorth Asset Management
13.75 %
3,002,880 13.75 % 252 242 €
1,108,002 5.073 % 93 072 €
823,492 3.770 % 69 173 €
431,332 1.975 % 36 232 €
173,180 0.7929 % 14 547 €
114,760 0.5254 % 9 640 €
80,500 0.3686 % 6 762 €
44,800 0.2051 % 3 763 €

Company contact information

Algernon Pharmaceuticals, Inc.

601 West Broadway Street Suite 400

V5Z 4C2, Vancouver

+604-398-4175

http://www.algernonpharmaceuticals.com
address Breathtec Biomedical Inc
  1. Stock Market
  2. Equities
  3. AGN Stock
  4. Stock
  5. Company Breathtec Biomedical Inc